N-acetylcysteine (NAC) shows promise to treat hereditary cystatin C amyloid angiopathy (HCCAA) HCCAA – a subtype of cerebral amyloid angiopathy (CAA) – is an ultra-rare Icelandic amyloid disease due to a mutation in the CST3 gene encoding for the protease inhibitor, cystatin C. HCCAA...
Read More Details
Finally We wish PressBee provided you with enough information of ( Arctic Therapeutics research suggests preventative strategy against HCCAA )
Also on site :
- LEGO Transforms Legendary Rock Band Into Custom Set
- One dead and two injured after stabbing attack at German company
- Bryan Kohberger to plead guilty in Idaho killings to avoid execution